Multiple myeloma with acute light chain cast nephropathy.
Multiple myeloma with acute light chain cast nephropathy.
复制标题
DOI:
10.1038/s41408-023-00806-w
复制
发表时间:
2023-03-29
影响因子:
12.8
通讯作者:
Rajkumar, S. Vincent
中科院分区:
文献类型:
--
作者:
Leung, Nelson;Rajkumar, S. Vincent
Light chain cast nephropathy (LCCN) is a leading cause of acute kidney injury (AKI) in patients with multiple myeloma (MM) and is now defined as a myeloma defining event. While the long-term prognosis has improved with novel agents, short-term mortality remains significantly higher in patients with LCCN especially if the renal failure is not reversed. Recovery of renal function requires a rapid and significant reduction of the involved serum free light chain. Therefore, proper treatment of these patients is of the utmost importance. In this paper, we provide an algorithm for treatment of MM patients who present with biopsy-proven LCCN or in those where other causes of AKI have been ruled out. The algorithm is based on data from randomized trial whenever possible. When trial data is not available, our recommendations is based on non-randomized data and expert opinions on best practices. We recommend that all patients should enroll in a clinical trial if available prior to resorting to the treatment algorithm we outlined.
登录
查看更多内容
影响因子:
12.8
作者:
Gonsalves WI;Leung N;Rajkumar SV;Dispenzieri A;Lacy MQ;Hayman SR;Buadi FK;Dingli D;Kapoor P;Go RS;Lin Y;Russell SJ;Lust JA;Zeldenrust S;Kyle RA;Gertz MA;Kumar SK
通讯作者:
Kumar SK
影响因子:
--
作者:
FEEST, TG;BURGE, PS;COHEN, SL
通讯作者:
COHEN, SL
影响因子:
2.7
作者:
Ho, P. Joy;Moore, Elizabeth M.;Spencer, Andrew
通讯作者:
Spencer, Andrew
影响因子:
158.5
作者:
Kastritis, E.;Palladini, G.;Comenzo, R. L.
通讯作者:
Comenzo, R. L.
影响因子:
6.2
作者:
Jagannath, S;Barlogie, B;Anderson, KC
通讯作者:
Anderson, KC